AAAAAA
Results:
1-20
|
Results: 20
Authors:
KEMPF DJ
RODE RA
XU Y
SUN E
HEATHCHIOZZI ME
VALDES J
JAPOUR AJ
DANNER S
BOUCHER C
MOLLA A
LEONARD JM
Citation: Dj. Kempf et al., THE DURATION OF VIRAL SUPPRESSION DURING PROTEASE INHIBITOR THERAPY FOR HIV-1 INFECTION IS PREDICTED BY PLASMA HIV-1 RNA AT THE NADIR, AIDS, 12(5), 1998, pp. 9-14
Authors:
MOLLA A
GRANNEMAN GR
SUN E
KEMPF DJ
Citation: A. Molla et al., RECENT DEVELOPMENTS IN HIV PROTEASE INHIBITOR THERAPY, Antiviral research, 39(1), 1998, pp. 1-23
Authors:
CAMERON DW
HEATHCHIOZZI M
DANNER S
COHEN C
KRAVCIK S
MAURATH C
SUN E
HENRY D
RODE R
POTTHOFF A
LEONARD J
Citation: Dw. Cameron et al., RANDOMIZED PLACEBO-CONTROLLED TRIAL OF RITONAVIR IN ADVANCED HIV-1 DISEASE, Lancet, 351(9102), 1998, pp. 543-549
Authors:
NAKAJIMA H
SUN E
MIZUTA N
FUJIWARA I
OKA T
Citation: H. Nakajima et al., FTY720 INHIBITS THE MESSENGER-RNA EXPRESSION OF INTRAGRAFT CYTOTOXIC MOLECULES, LEADING TO CARDIAC ALLOGRAFT SURVIVAL, Transplantation proceedings, 30(5), 1998, pp. 2217-2220
Authors:
ANGEL JB
KUMAR A
PARATO K
FILION LG
DIAZMITOMA F
DAFTARIAN P
PHAM B
SUN E
LEONARD JM
CAMERON DW
Citation: Jb. Angel et al., IMPROVEMENT IN CELL-MEDIATED IMMUNE FUNCTION DURING POTENT ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS THERAPY WITH RITONAVIR PLUS SAQUINAVIR, The Journal of infectious diseases, 177(4), 1998, pp. 898-904
Authors:
HSU A
GRANNEMAN GR
CAO GL
CAROTHERS L
ELSHOURBAGY T
BAROLDI P
ERDMAN K
BROWN F
SUN E
LEONARD JM
Citation: A. Hsu et al., PHARMACOKINETIC INTERACTIONS BETWEEN 2 HUMAN-IMMUNODEFICIENCY-VIRUS PROTEASE INHIBITORS, RITONAVIR AND SAQUINAVIR, Clinical pharmacology and therapeutics, 63(4), 1998, pp. 453-464
Authors:
ALBERT DH
MAGOC TJ
MENACHERRY SD
MORGAN DW
SUN E
REYES AE
KLEINERT HD
CARTER GW
SUMMERS JB
Citation: Dh. Albert et al., EX-VIVO INHIBITION OF BETA-THROMBOGLOBULIN RELEASE FOLLOWING ADMINISTRATION TO MAN OF ABT-299, A NOVEL PRODRUG OF A POTENT PLATELET-ACTIVATING-FACTOR ANTAGONIST, Inflammation research, 46(7), 1997, pp. 272-277
Authors:
XU F
ZHAO W
MA X
MA J
SUN E
KUMAKURA C
KUSUMOTO A
ASHIZAWA K
Citation: F. Xu et al., HEAD SHAPE VARIATION AMONG CHILDREN OF 4 CITIES IN EAST-ASIA, Anthropological science, 105(1), 1997, pp. 3-3
Authors:
KEMPF DJ
MARSH KC
KUMAR G
RODRIGUES AD
DENISSEN JF
MCDONALD E
KUKULKA MJ
HSU A
GRANNEMAN GR
BAROLDI PA
SUN E
PIZZUTI D
PLATTNER JJ
NORBECK DW
LEONARD JM
Citation: Dj. Kempf et al., PHARMACOKINETIC ENHANCEMENT OF INHIBITORS OF THE HUMAN-IMMUNODEFICIENCY-VIRUS PROTEASE BY COADMINISTRATION WITH RITONAVIR, Antimicrobial agents and chemotherapy, 41(3), 1997, pp. 654-660
Authors:
TUME CB
NGU JL
MCKERROW JL
SEIGEL J
SUN E
BARR PJ
BATHURST I
MORGAN G
NKENFOU C
ASONGANYI T
LANDO G
Citation: Cb. Tume et al., CHARACTERIZATION OF A RECOMBINANT ONCHOCERCA-VOLVULUS ANTIGEN (OV33) PRODUCED IN YEAST, The American journal of tropical medicine and hygiene, 57(5), 1997, pp. 626-633
Authors:
MORRE DJ
SUN E
GEILEN C
WU LY
DECABO R
KRASAGAKIS K
ORFANOS CE
MORRE DM
Citation: Dj. Morre et al., CAPSAICIN INHIBITS PLASMA-MEMBRANE NADH OXIDASE AND GROWTH OF HUMAN AND MOUSE MELANOMA LINES, European journal of cancer, 32A(11), 1996, pp. 1995-2003
Authors:
LUSTIG KD
KROLL K
SUN E
RAMOS R
ELMENDORF H
KIRSCHNER MW
Citation: Kd. Lustig et al., XENOPUS NODAL-RELATED GENE THAT ACTS IN SYNERGY WITH NOGGIN TO INDUCECOMPLETE SECONDARY AXIS AND NOTOCHORD FORMATION, Development, 122(10), 1996, pp. 3275-3282
Authors:
CAMERON DW
HSU A
GRANNEMAN GR
SUN E
MCMAHON D
FARTHING C
PORETZ D
MARKOWTIZ M
COHEN C
FOLLANSBEE S
MELLORS J
HO D
XU Y
RODE R
SALGO M
LEONARD J
Citation: Dw. Cameron et al., PHARMACOKINETICS OF RITONAVIR-SAQUINAVIR COMBINATION THERAPY, AIDS, 10, 1996, pp. 56-56
Authors:
SUN E
DATTA A
LOBO S
Citation: E. Sun et al., COMPOSITION BASED PREDICTION OF DIELECTRIC-PROPERTIES OF FOODS, The Journal of microwave power and electromagnetic energy, 30(4), 1995, pp. 205-212
Authors:
TUME C
SUN E
TITANJI V
BATHURST I
BARR P
HOUGH M
WEISS N
CHAKRAVARTI B
WAHI M
LACKEY A
STAUNTON C
LUSTIGMAN S
MCKERROW JH
Citation: C. Tume et al., ONCHOCERCA-VOLVULUS - IDENTIFICATION AND CHARACTERIZATION OF AN IMMUNOGENIC EGGSHELL PROTEIN (OVEG-1), Experimental parasitology, 81(4), 1995, pp. 445-452
Authors:
SUN E
LAWRENCE J
MORRE DM
SUN I
CRANE FL
MACKELLAR WC
MORRE DJ
Citation: E. Sun et al., PROTON RELEASE FROM HELA-CELLS AND ALKALIZATION OF CYTOPLASM INDUCED BY DIFERRIC TRANSFERRIN OR FERRICYANIDE AND ITS INHIBITION BY THE DIARYLSULFONYLUREA ANTITUMOR DRUG N-(4-METHYLPHENYLSULFONYL)-N'-(4-CHOLOROPHENYL) UREA (LY181984), Biochemical pharmacology, 50(9), 1995, pp. 1461-1468
Authors:
CHEN X
RING C
SUN E
MCKERROW JH
LEE GK
ROSENTHAL PJ
KUNTZ ID
COHEN FE
Citation: X. Chen et al., STRUCTURE-BASED INHIBITOR SCREENING AND DESIGN FOR PARASITIC PROTEASES, Journal of cellular biochemistry, 1994, pp. 166-166
Authors:
SUN E
COHEN FE
Citation: E. Sun et Fe. Cohen, COMPUTER-ASSISTED DRUG DISCOVERY - A REVIEW, Gene, 137(1), 1993, pp. 127-132
Authors:
MCKERROW JH
SUN E
ROSENTHAL PJ
BOUVIER J
Citation: Jh. Mckerrow et al., THE PROTEASES AND PATHOGENICITY OF PARASITIC PROTOZOA, Annual review of microbiology, 47, 1993, pp. 821-853
STRUCTURE-BASED INHIBITOR DESIGN BY USING PROTEIN MODELS FOR THE DEVELOPMENT OF ANTIPARASITIC AGENTS
Authors:
RING CS
SUN E
MCKERROW JH
LEE GK
ROSENTHAL PJ
KUNTZ ID
COHEN FE
Citation: Cs. Ring et al., STRUCTURE-BASED INHIBITOR DESIGN BY USING PROTEIN MODELS FOR THE DEVELOPMENT OF ANTIPARASITIC AGENTS, Proceedings of the National Academy of Sciences of the United Statesof America, 90(8), 1993, pp. 3583-3587
Risultati:
1-20
|